Cancer Care

 

 
ACNS1123 Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Principal Investigator (?)
Study Number
ACNS1123
Summary
Drugs used as chemotherapy, such as carboplatin, etoposide, and ifosfamide work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Radiation therapy uses high-energy x rays to kill tumor cells. Giving chemotherapy
with radiation therapy may kill more tumor cells. This phase II trial studies how well
chemotherapy and radiation therapy work in treating younger patients with newly diagnosed
central nervous system germ cell tumors.
Phase (?)
Phase II
Sponsor (?)
Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.